Findings from MU study could help identify people at-risk
Help may be on the way for people who might lose contact with reality through a psychotic disorder, such as schizophrenia.
People who may hear and see things that are not there could have symptoms of psychosis, better known as psychotic disorders. Now, researchers at the University of Missouri have found neurological markers in the human brain that can be used to detect people at-risk for developing psychotic disorders and to understand when this risk has been successfully treated.
“Psychotic disorders like schizophrenia are often lifelong and disabling for individuals,” said John Kerns, professor of psychology in the MU College of Arts and Science. “These disorders have major public health and societal costs greater than cancer. A major goal of our current research is to understand the nature of psychosis risk so we can prevent years of suffering.”
Researchers said psychotic disorders are associated with increased levels of dopamine — a chemical released by nerve cells — in a subregion of the brain called the striatum. This area is wired to process positive versus negative feedback for learning, often resulting in a person’s thoughts and actions based on what they’ve experienced in the past. Therefore, researchers suggest that psychotic disorders involve a faulty feedback in learning that then drives a person’s faulty beliefs and perceptions. However, measuring levels of dopamine in people is costly, invasive and not feasible in everyday clinical practice. In this new study, MU researchers used an MRI at MU’s Brain Imaging Center and found that people at risk for psychotic disorders exhibit evidence of dysfunction in the striatum.
“This dysfunction is most evident when performing tasks where people need to learn from positive and negative feedback,” Kerns said. “For instance, we have found that the risk for psychotic disorders involves increased activation in the striatum for positive feedback, and negative feedback involves decreased activation in the same subregion of the brain.”
Researchers believe this pattern of activation could explain symptoms of psychotic disorders. For example, activation resulting from increased positive feedback could make a person’s assumption seem truer than it really is, meanwhile activation from decreased negative feedback could make someone less likely to discard negative ideas. The team will conduct future research to examine how well an MRI can predict the risk of psychotic disorders and whether prevention treatments can ‘normalize’ MRI scans. They hope that their research will help prevent psychotic disorders, improve the lives of millions of people and greatly reduce public health costs.
The Latest on: Neurological brain markers
via Google News
The Latest on: Neurological brain markers
- What If You Never Get Better From Covid-19?on January 21, 2021 at 2:00 am
Some patients could be living with the aftereffects for years to come. Recent research into another persistent, mysterious disease might help us understand how to treat them.
- Blood Biomarker May Predict Alzheimer's Disease Progressionon January 20, 2021 at 12:14 pm
Changes in plasma levels of p-tau181 are associated with progressive cognitive decline and reduction in gray matter volume in patients with amyloid beta.
- What to do if a pregnancy is diagnosed with neural defectson January 17, 2021 at 5:48 am
Often, the screening test is an ultrasound which picks up abnormalities in the child. Most couples are still in doubt about these findings at the first go ...
- No inflammation of cerebrospinal fluid in COVID-19 patients with neurological features, study findson January 16, 2021 at 4:12 pm
Neurofilament light chain was used as a marker of neuroaxonal damage ... This aspect deserves further study, especially in relation to the brain fog and other long-haul neurological manifestations ...
- Plasma P-Tau181 Predicts, Monitors Alzheimer’s Progressionon January 15, 2021 at 4:00 pm
Tracking neurodegenerative changes in humans is key to learning more about Alzheimer’s disease progression. Recent studies have suggested that blood-based biomarkers may be useful in detecting AD ...
- Alzheimer's Progression Tracks With Blood Biomarkerson January 12, 2021 at 3:11 pm
Blood-based biomarkers paralleled the progression of Alzheimer's disease neurodegeneration, a large longitudinal cohort study showed. Increases of phosphorylated tau at threonine 181 (p-tau181) in ...
- CXCL13, Inflammatory Marker, May Be Good at Predicting Likely MS Activityon January 7, 2021 at 10:17 am
CXCL13, an inflammatory biomarker, may be a good marker of likely future disease activity in people with multiple sclerosis (MS), a study suggests. The study, “Intrathecally produced CXCL13: A ...
- Human Fetuses Can Contract SARS-CoV-2, but It’s Rareon January 7, 2021 at 8:04 am
When Roberts and Torous, who are both pathologists at Massachusetts General Hospital in Boston, ordered tests of the placental tissue for markers ... born with neurological abnormalities still had ...
- Maintaining a healthy heart and reducing arterial stiffening may help to prevent dementia in later life, study findson January 5, 2021 at 3:45 pm
These markers included lower brain blood supply ... Dementia is an umbrella term used to describe a range of progressive neurological disorders (those affecting the brain) which impact memory ...
- Challenges Facing Transplant Patients in COVID-19 Eraon January 5, 2021 at 10:13 am
For example, remdesivir increases the level of transaminase, which requires close monitoring of liver markers with transplant patients. 1 Another challenge is the lack of a test that is sensitive ...
via Bing News